DRKS00029641招募中不适用
Development of new approaches for immunotherapy of non-small cell lung cancer
Molekulare PneumologieUniversitätsklinikum Erlangen0 个研究点开始时间: 2022年7月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Lung tumor patients and control patients with indication for VATS:
- •Male and female patients 18 years of age and older with a diagnosis of lung cancer who meet the following additional criteria during clinical intervention will be included:
- •-Completion of a thoracoscopic-guided (VATS = video-assisted thoracic surgery) or open surgical procedure on the lung; and
- •-performance of a blood sampling procedure and/or
- •-performing an ultrasound-guided, percutaneous diagnostic or therapeutic puncture of the pleural cavity (effusion, empyema) or a pleural mass and/or
- •-performance of a bronchoscopy using a flexible or rigid technique (with endobronchial ultrasound: EBUS, if necessary) and/or
- •-Performing a bronchoscopy with bronchial lavage.
- •Healthy controls:
- •-Healthy adults with no past or current tumor diagnosis.
- •-Non-smokers
- •Smoker controls:
- •-Healthy adults with no past or current tumor diagnosis.
- •-Regular tobacco consumption for at least 1 year.
排除标准
- •Lung tumor patients and control patients with indications for VATS:
- •-Autoimmune diseases
- •-Severe chron. Diseases
- •-Other cancer types
- •Healthy controls and smokers:
- •-Autoimmune diseases
- •-Severe chron. Diseases
- •-Malignant diseases
研究者
相似试验
Unknown
不适用
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35
招募中
Unknown
Development of Novel Immunotherapy for Canceriquid and Solid TumorsJPRN-UMIN000052314Ehime University Graduate School of Medicine20
招募中
不适用
Study for development of new treatment for antibody mediated rejection in organ transplantatioorgan failureJPRN-UMIN000030525Tokyo Women's Medical University41
尚未招募
Unknown
To find Natural killers cells as a treatment option for Triple negative breast cancer.CTRI/2023/10/058292Tata Memorial Center
进行中（未招募）
1 期
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)Immune thrombocytopeniaMedDRA version: 23.0Level: PTClassification code: 10083842Term: Immune thrombocytopenia Class: 100000004851CTIS2023-505788-35-00Fakultni Nemocnice Hradec Kralove73